← Back to all trials
Recruiting
NCT05689801
Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life
Conditions: Terminal Renal Insufficiency
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 20
Sponsor: Ramsay Générale de Santé
Location: France
Summary
In this study, the effect of optimizing the dialytic technique using simple questionnaires carried out in clinical routine will be described.More specifically, the conventional dialysis technique will be combined with biofeedback software called HemoControl™.
The recovery time and quality of life of patients who will use a polyethersulfone membrane (Revaclear®) and a Medium Cut-Off (MCO) membrane (Theranova®) will be observed.The main objective is to describe the evolution of recovery time after a dialysis session in conventional hemodialysis (HD) on Revaclear® membrane and in so-called optimized hemodialysis (HDx) on MCO membrane, Theranova®.
Eligibility Criteria
Inclusion Criteria:Patient, male or female (using contraceptives, if of childbearing age), over 18 years of agePatient on conventional hemodialysis with synthetic membrane for at least 3 monthsPatient with a recovery time after the dialysis session ≥ 4 hoursInformed patient who has signed a written consent to participate in the studyAffiliated patient or beneficiary of a social security schemeExclusion Criteria:Patient whose seniority of dialysis is less than 3 monthsPregnant womanProtected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decisionPatient with severe cognitive impairmentMedically unstable or frail patientPatient who did not sign an informed consent form accepting this research (refusal of consent or absence of signature).
Source: ClinicalTrials.gov (NCT05689801). StuddyBuddy aggregates publicly available trial information.